SS&C Announces Allocation of $240.0 Million of Incremental Term A-9 Loans and $400.0 Million Revolving Credit Facility Upsize and Launch of $500.0 Million of Incremental Term B-8 Loans
In connection with the incurrence of the Incremental Term A-9 Loans and the Revolver Upsize,
The consummation of the Credit Agreement Transactions is subject to market and other conditions, including the negotiation and execution of definitive documentation, and the Credit Agreement Transactions are anticipated to close in the fourth quarter of 2026. However, there can be no assurance the Company will be able to successfully complete the transactions, on the terms described above, or at all. If all of the Credit Agreement Transactions are completed as described above, upon the closing of the Credit Agreement Transactions: the principal amount of term “A” loans outstanding under the Credit Agreement would be
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities or other indebtedness, nor shall there be any offer, solicitation or sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
About SS&C Technologies
SS&C is a leading provider of mission-critical, AI-powered technology and services empowering financial services and healthcare organizations to work smarter, faster, and securely. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices worldwide. More than 23,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale and technology.
Caution Regarding Forward-Looking Statements
Certain information contained in this press release constitutes forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, statements relating to the Credit Agreement Transactions, the anticipated use of the proceeds therefrom, the incurrence of incremental long-term indebtedness, the refinancing of the 2027 Senior Notes, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261101716648/en/
For more information
Brian Schell
Chief Financial Officer
Tel: +1-816-642-0915
E-mail: InvestorRelations@sscinc.com
Justine Stone
Head of Investor Relations
Tel: +1-212-367-4705
E-mail: InvestorRelations@sscinc.com
Source: SS&C
